MedChemComm · 2017 · 56 citations · 25 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular OncologySynthetic Medicinal ChemistryCytotoxic ChemotherapyOncology PharmacologyPharmacodynamics Of Anticancer AgentsAnticancer ChemotherapyAntiproliferative AgentsAntiproliferative Drug ActionBiological Evaluation ReportPyrazole ChemistryPyrimidine AnalogsPyrimidine AnaloguesPyrimidine Chemistry
of 2.6 μM . The antiproliferative activity of this series of compounds ranged from 2.6 to 34.9 μM against A549 (lung cancer), MDA-MB-231 (breast cancer) and DU-145 (prostate cancer) cell lines. FACS analysis revealed that these hybrids arrest the cell cycle at the subG1 phase. Western blot analysis and an immunofluorescence assay showed the inhibition of the EGFR and STAT3 axis, which plays an important role in cell survival and apoptosis. Western blot and RT-PCR analyses that displayed an increase in apoptotic proteins such as p53, p21 and Bax and a decrease in the anti-apoptotic proteins Bcl-2 and procaspase-9 confirmed the ability of these hybrids to trigger cell death by apoptosis. Molecular docking studies described the binding of these hybrids to the ATP binding site of EGFR.
25
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text
Stéphane Temam, Hidetoshi Kawaguchi, Adel K. El‐Naggar et al. · Journal of Clinical Oncology · 2007 · 400 citations · Full text